Accelerating ADC Development and Manufacturing with ThioBridge™ Conjugation and Linker Technology

  • ThioBridgeTM conjugation technology insights; how the technology works, and its advantages over stochastic conjugation technologies.
  • Modulation of Drug-Antibody Ratio (DAR) using ThioBridge as effective feature to optimize therapeutic activity.
  • In vitro and in vivo stability of ADCs generated using ThioBridgeTM
  • Optimization of linker architecture to enhance in vivo efficacy of ThioBridgeTM ADCs. In vivo data for relevant ADCs generated using ThioBridgeTM technology
  • ThioBridgeTM linker-payload and ADC manufacturing considerations.